Key Takeaways
- Bank of America revised AppLovin (APP) from Buy to Neutral, reducing the price target from $430 to $400.
- Shares of APP declined 2% during premarket hours after the downgrade announcement.
- Analyst Omar Dessouky from BofA highlighted increasing risks to the company’s long-term 30% year-over-year revenue growth objective.
- The previously observed self-learning quarterly growth mechanism of 3-5% may no longer be viable due to AppLovin’s dominant market position.
- The stock has fallen 45% year-to-date, with numerous Wall Street analysts downgrading shares following Q2 earnings.
Shares of AppLovin (APP) fell 2% in premarket activity on Monday following Bank of America’s decision to downgrade the stock from Buy to Neutral.
Omar Dessouky, a BofA analyst, lowered the firm’s price target to $400 from the previous $430, citing mounting concerns regarding AppLovin’s capacity to maintain its ambitious long-term growth goals.
This downgrade arrives during a challenging period for APP shareholders. Shares have tumbled 45% year-to-date and have faced multiple downgrades from various Wall Street analysts since the company released its second-quarter earnings earlier this month.
Dessouky’s primary worry centers on AppLovin’s publicly stated objective of delivering 30% year-over-year revenue growth over the long term. According to the analyst, the probability of missing that target has increased.
Following the Q2 report, engineer-led enhancements to Gaming models seem to be driving the majority of sequential quarterly growth. This represents a departure from the previously more autonomous growth pattern the company enjoyed.
Questions Emerge Around Self-Learning Capabilities
Previously, AppLovin benefited from what analysts characterized as a self-reinforcing mechanism within its advertising models, producing organic quarterly expansion of 3-5% without significant manual adjustments.
Dessouky now expresses uncertainty about whether this growth rate remains achievable. Notably, the company avoided directly discussing the future trajectory of self-learning growth during its Q2 earnings conference call, in Q3 guidance materials, or in subsequent investor communications.
This lack of clarity is creating concern among investors. Should self-learning growth have reached a ceiling, the company would need to rely more heavily on new product launches or external growth catalysts to maintain momentum.
BofA also highlighted AppLovin’s commanding market position as both an advantage and a potential limitation. The firm calculates that APP commands approximately twice the market share of its closest rival.
At such a dominant scale, maintaining a 3% quarterly self-learning growth rate becomes increasingly challenging. The opportunity for organic expansion diminishes when a company already controls a substantial portion of its addressable market.
Changing Risk Assessment
BofA opted to maintain APP’s current valuation multiple. The firm does not anticipate AppLovin surrendering its market leadership position entirely.
However, Dessouky indicated that investors may increasingly view AppLovin as a mature adtech business rather than a high-growth technology company, unless the firm introduces a significant new innovation cycle.
This repositioning represents an important narrative change. It implies that justifying the stock’s growth-oriented valuation premium may become more difficult in the future.
AppLovin had been regarded as among the most innovative players in mobile advertising technology, with its artificial intelligence-powered advertising platform attracting substantial investor enthusiasm throughout 2024 and into early 2025.
At the time BofA issued its updated price target, APP was trading near the $400 mark, indicating the new target implies minimal upside potential from current trading levels based on the analyst’s assessment.
The second-quarter results marked an inflection point. Several firms initiated downgrades following the earnings release, with BofA now joining the list of firms taking a more cautious stance.
Dessouky’s research note to institutional clients was distributed on August 11, 2026, with the Neutral rating and $400 price target becoming effective immediately.





